As race for COVID-19 vaccine picks up, Norway announces additional US$223 million to CEPI

Norway is increasing funding for the development of a COVID-19 vaccine. NOK 2.2 billion (US$223 million) will be allocated to the Coalition for Epidemic Preparedness Innovations (CEPI), over the next ten years. 

Norway announced as early as January that it was allocating NOK 36 million (US$4 million) to CEPI’s work to develop a vaccine against COVID-19. This funding is in addition to Norway’s ordinary contribution to CEPI, which will total NOK 1.6 billion (US$178 million) for the period 2017- 2025.  

Norway played a key role in establishing CEPI, a global coalition that works to prevent epidemics and pandemics and develop new vaccines against infectious diseases. Norway, together with the Bill and Melinda Gates Foundation, the Wellcom Trust, and a consortium of nations including Japan and Germany, launched CEPI in Davos during the World Economic Forum in 2017. 

Press release – Norwegian Government